| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes1
,
,
,,
* Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5535, Montpellier, France;
Institut de Génétique Moléculaire de Montpellier, Montpellier, France;
Université Montpellier, Montpellier, France;
Institut Fédératif de Recherche 122, Montpellier, France;
¶ Institut National de la Santé et de la Recherche Médicale, Unité 758, Lyon, France;
|| Ecole Normale Supérieure de Lyon, Lyon, France; and
# Institut Fédératif de Recherche 128, BioSciences Lyon-Gerland, Lyon, France
IL-7 plays a major role in T lymphocyte homeostasis and has been proposed as an immune adjuvant for lymphopenic patients. This prospect is based, at least in part, on the short-term expansion of peripheral T cells in rIL7-treated mice and primates. Nevertheless, in vivo, following initial increases in T cell proliferation and numbers, lymphocytes return to a quiescent state. As the bases for this cell cycle exit have not yet been elucidated, it is important to assess the long-term biological effects of IL-7 on quiescent human T lymphocyte subsets. In this study, we find that IL-7-stimulated CD4+ naive lymphocytes enter into cell cycle with significantly delayed kinetics as compared with the memory population. Importantly though, these lymphocytes exit from the cell cycle despite the continuous replenishment of rIL-7. This response is distinct in memory and naive CD4+ lymphocytes with memory cells starting to exit from cycle by day 10 vs day 18 for naive cells. Return to quiescence is associated with a cessation in IL-7R signaling as demonstrated by an abrogation of STAT-5 phosphorylation, despite an up-regulation of surface IL-7R
. Indeed, an initial 10-fold decrease in IL-7R mRNA levels is followed by increased IL-7R expression in naive as well as memory T cells, with kinetics paralleling cell cycle exit. Altogether, our data demonstrate that IL-7 promotes the extended survival of both naive and memory CD4+ T cells, whereas cycling of these two subsets is distinct and transient. Thus, IL-7 therapy should be designed to allow optimal responsiveness of naive and memory T cell subsets.
This article has been cited by other articles:
|
|
 |
|
  S. E. Johnson, N. Shah, A. A. Bajer, and T. W. LeBien IL-7 Activates the Phosphatidylinositol 3-Kinase/AKT Pathway in Normal Human Thymocytes but Not Normal Human B Cell Precursors J. Immunol., June 15, 2008; 180(12): 8109 - 8117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Alves, E. M. M. van Leeuwen, I. A. M. Derks, and R. A. W. van Lier Differential Regulation of Human IL-7 Receptor {alpha} Expression by IL-7 and TCR Signaling J. Immunol., April 15, 2008; 180(8): 5201 - 5210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yang, J. An, and N.-p. Weng Telomerase Is Involved in IL-7-Mediated Differential Survival of Naive and Memory CD4+ T Cells J. Immunol., March 15, 2008; 180(6): 3775 - 3781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vranjkovic, A. M. Crawley, K. Gee, A. Kumar, and J. B. Angel IL-7 decreases IL-7 receptor {alpha} (CD127) expression and induces the shedding of CD127 by human CD8+ T cells Int. Immunol., December 1, 2007; 19(12): 1329 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yates, F. Rovis, P. Mitchell, B. Afzali, J.-S Tsang, M. Garin, R. Lechler, G. Lombardi, and O. Garden The maintenance of human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro Int. Immunol., June 1, 2007; 19(6): 785 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Swainson, S. Kinet, C. Mongellaz, M. Sourisseau, T. Henriques, and N. Taylor IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway Blood, February 1, 2007; 109(3): 1034 - 1042. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
